Published in Biochemistry on April 27, 1971
Complete inhibition of the expression of an idiotype by a mechanism of B-cell dominance. J Exp Med (1977) 1.11
Amino acid sequence of the N-terminal 139 residues of light chain derived from a homogeneous rabbit antibody. Biochem J (1974) 0.99
Comparison of the amino acid sequences of the variable regions of light chains derived from two homogeneous rabbit anti-pneumococcal antibodies. Biochem J (1974) 0.89
Quantitative investigations of idiotypic antibodies. V. Factors affecting the persistence and replacement of clones of antibody-producing cells. J Exp Med (1971) 0.88
Human triclonal anti-IgG gammopathy. III. Determination of the clonal persistence of the IgM autoantibody for a four and one-half year period. Immunology (1978) 0.87
Amino-acid sequences of light chains of a rabbit anti-p-azobenzoate antibody. Proc Natl Acad Sci U S A (1971) 0.80
A comparison of the N-terminal amino acid sequences of early and late pools of anti-DNP and anti-DNP-p-aminobenzoylglutamate antibody light chains. Immunology (1978) 0.75
Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences. Nature (1984) 14.21
Phosphatidylinositol-3-OH kinase as a direct target of Ras. Nature (1994) 10.34
Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus. Nature (1983) 8.60
Synthesis and function of 3-phosphorylated inositol lipids. Annu Rev Biochem (2001) 8.47
Binding of immunogenic peptides to Ia histocompatibility molecules. Nature (1985) 8.39
Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (1985) 8.23
Phosphatidylinositol 3-kinase encoded by yeast VPS34 gene essential for protein sorting. Science (1993) 7.86
Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab (1969) 7.56
Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion. Proc Natl Acad Sci U S A (1982) 7.34
Role of phosphoinositide 3-OH kinase in cell transformation and control of the actin cytoskeleton by Ras. Cell (1997) 6.55
Determination of therapeutic and toxic serum digoxin concentrations by radioimmunoassay. N Engl J Med (1969) 6.15
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli. Proc Natl Acad Sci U S A (1988) 6.14
Multiple, distinct forms of bovine and human protein kinase C suggest diversity in cellular signaling pathways. Science (1986) 6.10
Cellular function of phosphoinositide 3-kinases: implications for development, homeostasis, and cancer. Annu Rev Cell Dev Biol (2001) 5.80
The application of 0.1 M quadrol to the microsequence of proteins and the sequence of tryptic peptides. Biochemistry (1975) 5.31
Autophosphorylation sites on the epidermal growth factor receptor. Nature (1984) 5.11
Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res (1999) 4.79
Phosphatidylinositol-3-OH kinases are Rab5 effectors. Nat Cell Biol (1999) 4.76
Phosphoinositide 3-kinases: a conserved family of signal transducers. Trends Biochem Sci (1997) 4.52
Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF receptor and v-erbB protein. Cell (1985) 4.02
The complete primary structure of protein kinase C--the major phorbol ester receptor. Science (1986) 4.02
Activation of phosphoinositide 3-kinase by interaction with Ras and by point mutation. EMBO J (1996) 3.99
The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J (1996) 3.78
Signalling through phosphoinositide 3-kinases: the lipids take centre stage. Curr Opin Cell Biol (1999) 3.47
Purification of the fusion protein of Sendai virus: analysis of the NH2-terminal sequence generated during precursor activation. Proc Natl Acad Sci U S A (1978) 3.42
Distinct specificity in the recognition of phosphoinositides by the pleckstrin homology domains of dynamin and Bruton's tyrosine kinase. EMBO J (1996) 3.41
Digitalis intoxication. A prospective clinical study with serum level correlations. N Engl J Med (1971) 3.27
A human phosphatidylinositol 3-kinase complex related to the yeast Vps34p-Vps15p protein sorting system. EMBO J (1995) 3.19
P110delta, a novel phosphoinositide 3-kinase in leukocytes. Proc Natl Acad Sci U S A (1997) 3.09
Antibodies involved in antigen-induced release of slow reacting substance of anaphylaxis (SRS-A) in the guinea pig and rat. J Exp Med (1967) 3.08
Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol (1996) 3.08
A monoclonal antibody to the human epidermal growth factor receptor. J Cell Biochem (1982) 3.04
PI 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J (1994) 3.02
Active site and complete sequence of the suicidal methyltransferase that counters alkylation mutagenesis. Proc Natl Acad Sci U S A (1985) 3.01
Large and small tumor antigens from simian virus 40 have identical amino termini mapping at 0.65 map units. Proc Natl Acad Sci U S A (1978) 3.00
Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature (1988) 2.99
Studies on the primary structure of the influenza virus hemagglutinin. Proc Natl Acad Sci U S A (1975) 2.88
Studies on migration inhibitory factor (MIF): recovery of MIF activity after purification by gel filtration and disc electrophoresis. Cell Immunol (1970) 2.86
Intestinal uptake of macromolecules: effect of oral immunization. Science (1972) 2.80
Regulation of imaginal disc cell size, cell number and organ size by Drosophila class I(A) phosphoinositide 3-kinase and its adaptor. Curr Biol (1999) 2.76
Digoxin intoxication: the relationship of clinical presentation to serum digoxin concentration. J Clin Invest (1970) 2.66
Immunoglobulins on the surface of neoplastic lymphocytes. N Engl J Med (1972) 2.63
Reversal of advanced digoxin intoxication with Fab fragments of digoxin-specific antibodies. N Engl J Med (1976) 2.49
Expression of a platelet-derived growth factor-like protein in simian sarcoma virus transformed cells. Science (1983) 2.41
Characterization of antibodies of high affinity and specificity for the digitalis glycoside digoxin. Biochemistry (1970) 2.39
The anaphylactic antibodies of mammals including man. Prog Allergy (1967) 2.38
Expression of epidermal growth factor receptors on human cervical, ovarian, and vulval carcinomas. Cancer Res (1986) 2.38
Correlation of c-erbB-2 gene amplification and protein expression in human breast carcinoma with nodal status and nuclear grading. Cancer Res (1988) 2.36
Tyr721 regulates specific binding of the CSF-1 receptor kinase insert to PI 3'-kinase SH2 domains: a model for SH2-mediated receptor-target interactions. EMBO J (1992) 2.29
Expression of the c-erbB-2 protein in normal and transformed cells. Int J Cancer (1987) 2.27
Antigenic competition at the level of peptide-Ia binding. Proc Natl Acad Sci U S A (1986) 2.23
Autophosphorylation and protein kinase C phosphorylation of the epidermal growth factor receptor. Effect on tyrosine kinase activity and ligand binding affinity. J Biol Chem (1985) 2.22
Solution structure and ligand-binding site of the SH3 domain of the p85 alpha subunit of phosphatidylinositol 3-kinase. Cell (1993) 2.20
Role of optical configuration in the immunogenicity and specificity of synthetic antigens derived from multichain polyproline. J Biol Chem (1968) 2.19
Defining the smallest analyte concentration an immunoassay can measure. Clin Chem (1996) 2.18
Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3. N Engl J Med (1973) 2.17
Brief report: recognition of acute myocarditis masquerading as acute myocardial infarction. N Engl J Med (1993) 2.14
Antigenic determinants in proteins coincide with surface regions accessible to large probes (antibody domains). Proc Natl Acad Sci U S A (1986) 2.13
Heart failure in outpatients: a randomized trial of digoxin versus placebo. N Engl J Med (1982) 2.09
Purification and properties of porcine platelet-derived growth factor. EMBO J (1984) 2.06
Purification and characterization of vaccinia virus growth factor. Cell (1985) 2.06
Activated phosphoinositide 3-kinase associates with membrane skeleton in thrombin-exposed platelets. J Biol Chem (1992) 2.04
Purification to homogeneity of protein kinase C from bovine brain--identity with the phorbol ester receptor. EMBO J (1984) 1.97
Distinct PI(3)Ks mediate mitogenic signalling and cell migration in macrophages. Nat Cell Biol (1999) 1.96
Hybridoma proteins expressing the predominant idiotype of the antiazophenylarsonate response of A/J mice. Proc Natl Acad Sci U S A (1980) 1.96
Classification of mouse VK groups based on the partial amino acid sequence to the first invariant tryptophan: impact of 14 new sequences from IgG myeloma proteins. Mol Immunol (1982) 1.93
Using structure to define the function of phosphoinositide 3-kinase family members. FEBS Lett (1997) 1.91
Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science (1983) 1.89
Immunologic relationship between blood group substances and a fucose-containing glycolipid of human adenocarcinoma. J Immunol (1967) 1.88
Hapten-specific IgE antibody responses in mice. I. Secondary IgE responses in irradiated recipients of syngeneic primed spleen cells. J Exp Med (1973) 1.87
Structure of an SH2 domain of the p85 alpha subunit of phosphatidylinositol-3-OH kinase. Nature (1992) 1.86
Thy-1, a novel marker for angiogenesis upregulated by inflammatory cytokines. Circ Res (1998) 1.81
A radioimmunoassay for bradykinin in plasma and synovial fluid. J Lab Clin Med (1969) 1.79
Characterization of p150, an adaptor protein for the human phosphatidylinositol (PtdIns) 3-kinase. Substrate presentation by phosphatidylinositol transfer protein to the p150.Ptdins 3-kinase complex. J Biol Chem (1997) 1.78
Cloning and functional analysis of the promoter for KDR/flk-1, a receptor for vascular endothelial growth factor. J Biol Chem (1995) 1.78
Evolution of antibody variable region structure during the immune response. Immunol Rev (1987) 1.77
Activation of Src family kinases by colony stimulating factor-1, and their association with its receptor. EMBO J (1993) 1.76
Molecular cloning and characterization of a novel p70 S6 kinase, p70 S6 kinase beta containing a proline-rich region. J Biol Chem (1998) 1.74
The nature of the antigenic determinant in a genetic control of the antibody response. J Exp Med (1969) 1.74
Heterogeneity in biologic functions of antibodies: implications for immunologic tumor enhancement. Fed Proc (1966) 1.72
In vitro, the major ribosome binding site on Rous sarcoma virus RNA does not contain the nucleotide sequence coding for the N-terminal amino acids of the gag gene product. J Virol (1979) 1.71
Interactions between SH2 domains and tyrosine-phosphorylated platelet-derived growth factor beta-receptor sequences: analysis of kinetic parameters by a novel biosensor-based approach. Mol Cell Biol (1993) 1.70
Antinuclear factors in synovia. Possible participants in the rheumatoid inclusion body. JAMA (1966) 1.67
Specificity of the T cell receptor: two different determinants are generated by the same peptide and the I-Ak molecule. J Immunol (1985) 1.67
Promotion of vascular smooth muscle cell growth by homocysteine: a link to atherosclerosis. Proc Natl Acad Sci U S A (1994) 1.66
Expression of a hybrid immunoglobulin-T cell receptor protein in transgenic mice. Cell (1989) 1.66
Platelet-derived growth factor elicits cyclic AMP accumulation in Swiss 3T3 cells: role of prostaglandin production. Cell (1983) 1.65
IgE and IgGa antibody-mediated release of histamine from rat peritoneal cells. I. Optimum conditions for in vitro preparation of target cells with antibody and and challenge with antigen. J Exp Med (1971) 1.64
Analysis of mammalian fibroblast transformation by normal and mutated human EGF receptors. Oncogene (1989) 1.64
Malignant seeding of the tract after thin-needle aspiration biopsy. Radiology (1979) 1.63
Digitalis (third of four parts). N Engl J Med (1973) 1.63
Cell-surface immunoglobulins in chronic lymphocytic leukemia and allied disorders. Am J Med (1973) 1.61
Amino acid sequence analysis with methyl isothiocyanate. Resolution of the methylthiohydantoins by gas-liquid partition chromatography. Biochemistry (1970) 1.61
Structure of antibody hypervariable loops reproduced by a conformational search algorithm. Nature (1988) 1.61
Cloning of a human phosphoinositide 3-kinase with a C2 domain that displays reduced sensitivity to the inhibitor wortmannin. Biochem J (1997) 1.60
Homocytotropic antibody response in the rat infected with the nematode, Nippostrongylus brasiliensis. II. Characteristics of the immune response. J Immunol (1968) 1.59
Use of o-phthalaldehyde to reduce background during automated Edman degradation. Anal Biochem (1984) 1.59